Delivery Order SPE2DB24D1107-SPE2DB24FZFC2

Award Date 7/25/24
Potential Completion Date 7/26/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 10mL vials of Humalog insulin. The $1,639.44 Firm Fixed Price Delivery Order has a period of performance extending to May 17, 2024. This award falls under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Humalog 100 Unit/mL insulin vials, with a ceiling value of $2,732.40 and a completion date of January 20, 2023. The contract is a firm fixed price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Humalog insulin vials to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,630.96 and a completion date of May 21, 2024. It is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a $7,317.86 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. This order is for 4,565,152,638 units of the drug Humalog (insulin lispro) in 10 mL vials, with a performance period through July 16, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with DLA Troop Support Medical, which serves as the...
This is a delivery order contract awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,109.78, is for the delivery of Humalog 100 unit/ml insulin vials. The contract has a firm fixed price pricing type and an ultimate completion date of August 7, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Humalog 100 unit/mL vial, a prescription insulin medication, with a ceiling value of $1,366.20 and a period of performance through September 2024. This delivery order is likely issued under a larger indefinite delivery contract (IDC) between AmerisourceBergen and the DLA, valued up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The contract is for the delivery of Humalog (insulin lispro), a medication used to treat diabetes, with a ceiling value of $1,466.04. The contract has a period of performance through June 6, 2023 and was awarded on a firm fixed-price basis. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also maintains a...
This is a delivery order under a federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Humalog 100 Unit/mL vial (10 mL), a type of insulin medication. The delivery order has a ceiling value of $1,821.60 and a completion date of September 24, 2024. This contract is not set aside for any specific business category. As a large pharmaceutical supplier,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide Humalog insulin vials (100 unit/mL, 10mL) for a ceiling value of $5,464.80. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,664.12 firm fixed-price delivery order is for the supply of Humalog 100 unit/mL vial, a 10 mL insulin medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range...
  • SPE2DB24D1107
    Indefinite Delivery Contract
  • SPE2DB24D1107-SPE2DB24FZFC2
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Humalog insulin vials, a critical diabetes medication, with a ceiling value of $1,639.44 and an ultimate completion date of July 26, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999, to provide a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation, and no subcontractors are mentioned. This award contributes to the DLA's mission of providing medical commodities and equipment to the U.S. military and other federal healthcare providers.

Generated 10/27/24, 4:13 AM